RxDoctor Payments Data

Jerry Sheen

Infectious Disease · Hillsborough, NJNPI 1851344915

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,107 of the $5,852 with a category attached, or 87.3%. It is spread thinly across 30 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,399 and has fallen 56.3% since, to $612 in 2025.

$5,852in general payments, 2019–2025

Across 205 payments — averaging $28.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$1K
  • KCI USA, Inc.$688
  • Paratek Pharmaceuticals, Inc.$664
  • Smith+Nephew$591
  • Musculoskeletal Transplant Foundation Inc.$411
  • Integra Lifesciences Corporation$400
  • plus $2K from 24 others

What the payments were for

  • Speaking & faculty fees$5009%
  • Food & beverage$5,10787%
  • Other$2454%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,852 in reported general payments places this provider in the 85th percentile of 334 infectious disease providers in New Jersey.

See all infectious disease providers in New Jersey

Medicare billing

Part B allowed, 2024
$341,443
Medicare patients
531
Services billed
3,433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip31$608
Triamcinolone Acetonide33$219
Cefadroxil21$143
Doxycycline Hyclate11$53

Paid to pharmacies, not to this prescriber.

Other infectious disease in Hillsborough

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →